Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
Background Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated t...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2024-04-01
|
Series: | Tuberculosis and Respiratory Diseases |
Subjects: | |
Online Access: | http://e-trd.org/upload/pdf/trd-2023-0126.pdf |
_version_ | 1827300328060485632 |
---|---|
author | Jeongsu Kim Jin Ho Jang Kipoong Kim Sunghoon Park Su Hwan Lee Onyu Park Tae Hwa Kim Hye Ju yeo Woo Hyun Cho |
author_facet | Jeongsu Kim Jin Ho Jang Kipoong Kim Sunghoon Park Su Hwan Lee Onyu Park Tae Hwa Kim Hye Ju yeo Woo Hyun Cho |
author_sort | Jeongsu Kim |
collection | DOAJ |
description | Background Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated the impact of obesity on outcomes in patients with severe COVID-19 in a Korean national cohort. A total of 1,114 patients were enrolled from 22 tertiary referral hospitals or university-affiliated hospitals, of whom 1,099 were included in the analysis, excluding 15 with unavailable height and weight information. The effect(s) of BMI on patients with severe COVID-19 were analyzed. Results According to the World Health Organization BMI classification, 59 patients were underweight, 541 were normal, 389 were overweight, and 110 were obese. The overall 28-day mortality rate was 15.3%, and there was no significant difference according to BMI. Univariate Cox analysis revealed that BMI was associated with 28-day mortality (hazard ratio, 0.96; p=0.045), but not in the multivariate analysis. Additionally, patients were divided into two groups based on BMI ≥25 kg/m2 and underwent propensity score matching analysis, in which the two groups exhibited no significant difference in mortality at 28 days. The median (interquartile range) clinical frailty scale score at discharge was higher in nonobese patients (3 [3 to 5] vs. 4 [3 to 6], p<0.001). The proportion of frail patients at discharge was significantly higher in the nonobese group (28.1% vs. 46.8%, p<0.001). Conclusion The obesity paradox was not evident in this cohort of patients with severe COVID-19. However, functional outcomes at discharge were better in the obese group. |
first_indexed | 2024-04-24T16:01:42Z |
format | Article |
id | doaj.art-707582ec06c94113aa5fc1a47840e614 |
institution | Directory Open Access Journal |
issn | 1738-3536 2005-6184 |
language | English |
last_indexed | 2024-04-24T16:01:42Z |
publishDate | 2024-04-01 |
publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
record_format | Article |
series | Tuberculosis and Respiratory Diseases |
spelling | doaj.art-707582ec06c94113aa5fc1a47840e6142024-04-01T07:30:27ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842024-04-0187217618410.4046/trd.2023.01264851Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter StudyJeongsu Kim0Jin Ho Jang1Kipoong Kim2Sunghoon Park3Su Hwan Lee4Onyu Park5Tae Hwa Kim6Hye Ju yeo7Woo Hyun Cho8 Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Republic of Korea Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of KoreaBackground Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated the impact of obesity on outcomes in patients with severe COVID-19 in a Korean national cohort. A total of 1,114 patients were enrolled from 22 tertiary referral hospitals or university-affiliated hospitals, of whom 1,099 were included in the analysis, excluding 15 with unavailable height and weight information. The effect(s) of BMI on patients with severe COVID-19 were analyzed. Results According to the World Health Organization BMI classification, 59 patients were underweight, 541 were normal, 389 were overweight, and 110 were obese. The overall 28-day mortality rate was 15.3%, and there was no significant difference according to BMI. Univariate Cox analysis revealed that BMI was associated with 28-day mortality (hazard ratio, 0.96; p=0.045), but not in the multivariate analysis. Additionally, patients were divided into two groups based on BMI ≥25 kg/m2 and underwent propensity score matching analysis, in which the two groups exhibited no significant difference in mortality at 28 days. The median (interquartile range) clinical frailty scale score at discharge was higher in nonobese patients (3 [3 to 5] vs. 4 [3 to 6], p<0.001). The proportion of frail patients at discharge was significantly higher in the nonobese group (28.1% vs. 46.8%, p<0.001). Conclusion The obesity paradox was not evident in this cohort of patients with severe COVID-19. However, functional outcomes at discharge were better in the obese group.http://e-trd.org/upload/pdf/trd-2023-0126.pdfbody mass indexcovid-19mortality |
spellingShingle | Jeongsu Kim Jin Ho Jang Kipoong Kim Sunghoon Park Su Hwan Lee Onyu Park Tae Hwa Kim Hye Ju yeo Woo Hyun Cho Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study Tuberculosis and Respiratory Diseases body mass index covid-19 mortality |
title | Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study |
title_full | Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study |
title_fullStr | Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study |
title_full_unstemmed | Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study |
title_short | Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study |
title_sort | functional aspects of the obesity paradox in patients with severe coronavirus disease 2019 a retrospective multicenter study |
topic | body mass index covid-19 mortality |
url | http://e-trd.org/upload/pdf/trd-2023-0126.pdf |
work_keys_str_mv | AT jeongsukim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT jinhojang functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT kipoongkim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT sunghoonpark functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT suhwanlee functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT onyupark functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT taehwakim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT hyejuyeo functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy AT woohyuncho functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy |